Document is current

Any future updates will be listed below

Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial

Crossref DOI link: https://doi.org/10.1007/s00134-022-06668-3

Published Online: 2022-03-18

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark